[ad_1] Collaboration will combine Zealand Pharma’s expertise in obesity and metabolic health with OTR Therapeutics’ proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic […]
Tag: Health Care & Hospitals
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025
[ad_1] HONG KONG, Dec. 10, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific […]
Olympus Partners Announces Promotion
[ad_1] STAMFORD, Conn., Dec. 10, 2025 /PRNewswire/ — Olympus Partners is pleased to announce that as of Jan. 1, 2026, Sam Greenberg is promoted to Partner. Sam joined Olympus in 2015 from Lazard & Co. He […]
Die Fondazione Telethon gibt die FDA-Zulassung von Waskyra™ (Etuvetidigene Autotemcel) bekannt, einer Gentherapie zur Behandlung des Wiskott-Aldrich-Syndroms USA – Deutsch USA – English USA – English Italia – Italiano USA – Français USA – español
[ad_1] WAS betrifft fast ausschließlich Männer, mit einer geschätzten Inzidenz von 1 zu 250.000 Lebensgeburten männlicher Kinder. Die Therapie stellt eine große wissenschaftliche und klinische Errungenschaft dar und gibt den betroffenen Patienten neue Hoffnung. ROM, […]
Senhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold Tumors
[ad_1] TAIPEI and SAN DIEGO, Dec. 10, 2025 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company developing first-in-class therapies for difficult-to-treat cancers, today announced a clinical supply agreement with BeOne Medicines, a global […]
